Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Vox Sanguinis
|
July 14, 2001
Solvent/detergent treatment does not alter the tolerance or uptake of human normal immunoglobulin for intramuscular injection
G P Mould, J A Sutton, P Matejtschuk, et al.
The Practitioner
|
March 1, 1982
A new dry powder inhaler
G M Pover, A K Browning, B M Mullinger, et al.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1984
Extraction of ceftazidime in bone
S P Hughes, I D McCarthy, R M Fleming, et al.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1986
The volume of distribution of ceftazidime and albumin in normal, immature and infected bone
M R Pinto, R H Fleming, S P Hughes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 25, 2011
Clinical experience with Optivate®, high-purity factor VIII (FVIII) product with von Willebrand factor (VWF) in young children with haemophilia A
M Matysiak, H Bobrowska, W Balwierz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 5, 2011
Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery
C R M Hay, A Hellmann, A Dmoszynska, et al.
Thorax
|
May 1, 1980
Sputum and blood concentrations of cefuroxime in lower respiratory tract infection
C W Havard, R P Bax, T C Samanta, et al.
Clinical and Experimental Immunology
|
August 8, 2007
The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies
G E Chapman, J R Ballinger, M J Norton, et al.
Clinical and Experimental Immunology
|
November 13, 2010
Efficacy and safety of a new immunoglobulin G product, Gammaplex(®), in primary immunodeficiency diseases
J N Moy, A M Scharenberg, M R Stein, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Vox Sanguinis
|
July 14, 2001
Solvent/detergent treatment does not alter the tolerance or uptake of human normal immunoglobulin for intramuscular injection
G P Mould, J A Sutton, P Matejtschuk, et al.
The Practitioner
|
March 1, 1982
A new dry powder inhaler
G M Pover, A K Browning, B M Mullinger, et al.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1984
Extraction of ceftazidime in bone
S P Hughes, I D McCarthy, R M Fleming, et al.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1986
The volume of distribution of ceftazidime and albumin in normal, immature and infected bone
M R Pinto, R H Fleming, S P Hughes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 25, 2011
Clinical experience with Optivate®, high-purity factor VIII (FVIII) product with von Willebrand factor (VWF) in young children with haemophilia A
M Matysiak, H Bobrowska, W Balwierz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 5, 2011
Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery
C R M Hay, A Hellmann, A Dmoszynska, et al.
Thorax
|
May 1, 1980
Sputum and blood concentrations of cefuroxime in lower respiratory tract infection
C W Havard, R P Bax, T C Samanta, et al.
Clinical and Experimental Immunology
|
August 8, 2007
The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies
G E Chapman, J R Ballinger, M J Norton, et al.
Clinical and Experimental Immunology
|
November 13, 2010
Efficacy and safety of a new immunoglobulin G product, Gammaplex(®), in primary immunodeficiency diseases
J N Moy, A M Scharenberg, M R Stein, et al.
Page
of 5